Feedback (FDBK)

Sector:

Health Care

Index:

FTSE AIM All-Share

75.00p
   
  • Change Today:
      7.50p
  • 52 Week High: 140.00p
  • 52 Week Low: 58.00p
  • Currency: UK Pounds
  • Shares Issued: 13.33m
  • Volume: 53,502
  • Market Cap: £10.00m
  • RiskGrade: 267

Feedback loss widens as company woos customers

By Josh White

Date: Monday 26 Feb 2018

LONDON (ShareCast) - (ShareCast News) - Specialist medical imaging technology company Feedback announced its unaudited results for the six months ended 30 November on Monday, with revenue rising to £0.22m from £0.2m a year earlier.
The AIM-traded firm's loss after tax widened to £0.35m from £0.13m, while its loss before interest, tax and amortisation for the six month period was £0.34m, compared to £0.12m.

Cash as at 30 November stood at £0.27m.

On the operational front, the company's board highlighted the signing of exclusive 'TexRAD' distributor agreements in China and Korea, along with the CE-marked release of 'TexRAD Lung'.

Three pilot TexRAD Lung installations were secured with existing research customers, with the board also reporting "significant" TexRAD research interest including 19 presentations at the RSNA annual conference.

Certification was received by CCI for ISO 13485:2016 quality management standard compliance.

"We continue to see strong demand for our technology across the global territories which has contributed to double-digit revenue growth during the period," said chief executive David Crabb.

"As a small team, we experienced some operational delays over the past 12 months which slowed our commercial progress, however the first CE marked release of the TexRAD technology in November was a major achievement for the Company and will underpin the next stage of growth."

Crabb said the company's mission is to create evidence-based imaging software, arming clinicians with innovative tools to improve patient outcomes.

"Having joined the company earlier this month, I will be refining the commercial strategy and growth ambitions to ensure that Feedback is well-positioned to deliver.

"In the near-term, with a CE marked product, distribution partners in key territories and ongoing discussions with global players, we are focused on developing our clinical evidence base and accelerating our market penetration in the rapidly growing medical imaging field."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Feedback Market Data

Currency UK Pounds
Share Price 75.00p
Change Today 7.50p
% Change 11.11 %
52 Week High 140.00p
52 Week Low 58.00p
Volume 53,502
Shares Issued 13.33m
Market Cap £10.00m
RiskGrade 267

Feedback Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.74% below the market average14.74% below the market average14.74% below the market average14.74% below the market average14.74% below the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Price Trend
41.93% below the market average41.93% below the market average41.93% below the market average41.93% below the market average41.93% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Income Not Available
Growth
52.86% above the market average52.86% above the market average52.86% above the market average52.86% above the market average52.86% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Feedback Dividends

No dividends found

Trades for 14-Jun-2024

Time Volume / Share Price
16:29 1,303 @ 76.70p
16:29 1,317 @ 75.90p
16:27 777 @ 73.80p
16:26 5,000 @ 73.25p
16:16 1,000 @ 77.00p

Feedback Key Personnel

CEO Tom Oakley
CFO Anesh Patel

Top of Page